Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells

被引：56

作者：

Bontkes, Hetty J. ^{[1
]}

Kramer, Duco ^{[1
]}

Ruizendaal, Janneke J. ^{[1
]}

Meijer, Chris J. L. M. ^{[1
]}

Hooijberg, Erik ^{[1
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands

来源：

CLINICAL IMMUNOLOGY | 2008年 / 127卷 / 03期

关键词：

human; dendritic cells; natural killer cells; cytokines; vaccination;

D O I：

10.1016/j.clim.2008.02.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunotherapy aiming at the combined activation of tumor associated antigen (TAA) specific cytotoxic T lymphocytes (CTL) and Natural Killer (NK) cells may be crucial to eradicate both MHC-I positive and negative tumors. Vaccination with mature dendritic cells (DC) transfected with mRNA encoding for TAA and the pro-inflammatory cytokines interteukin (IL)-12 and IL-18 may increase NK cell and TAA specific CTL activity. We demonstrate here that IL-12 over-expressing human DC induces increased NK cell activation and effector function and confirm the increase in TAA specific CTL by TAA/IL-12 double transfected DC. The effects of IL-18 transfection were limited to phenotypic activation and down-regulation of tissue homing receptors and did not add to the effect of IL-12 on NK cell effector function. In conclusion, co-transfection of TAA and IL-12 mRNA into mature DCs offers a vaccine for the induction of an antitumor immune response mediated by CTL and NK effector cells. (c) 2008 Elsevier Inc. All rights reserved.

引用

页码：375 / 384

页数：10

共 38 条

[11] NK cell and DC interactions [J].

Cooper, MA ;

Fehniger, TA ;

Fuchs, A ;

Colonna, M ;

Caligiuri, MA .

TRENDS IN IMMUNOLOGY, 2004, 25 (01) :47-52

[12] The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells [J].

Ferlazzo, G ;

Morandi, B ;

D'Agostino, A ;

Meazza, R ;

Melioli, G ;

Moretta, A ;

Moretta, L .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) :306-313

[13] Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme [J].

Gu, Y ;

Kuida, K ;

Tsutsui, H ;

Ku, G ;

Hsiao, K ;

Fleming, MA ;

Hayashi, N ;

Higashino, K ;

Okamura, H ;

Nakanishi, K ;

Kurimoto, M ;

Tanimoto, T ;

Flavell, RA ;

Sato, V ;

Harding, MW ;

Livingston, DJ ;

Su, MSS .

SCIENCE, 1997, 275 (5297) :206-209

[14]

Hagenaars M, 1998, INT J CANCER, V78, P783, DOI 10.1002/(SICI)1097-0215(19981209)78:6<783::AID-IJC17>3.0.CO

[15]

2-C

[16] Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity [J].

Hwang, KS ;

Cho, WK ;

Yoo, J ;

Seong, YR ;

Kim, BK ;

Kim, S ;

Im, DS .

CANCER GENE THERAPY, 2004, 11 (06) :397-407

[17] Helper role of NK cells during the induction of anticancer responses by dendritic cells [J].

Kalinski, P ;

Giermasz, A ;

Nakamura, Y ;

Basse, P ;

Storkus, WJ ;

Kirkwood, JM ;

Mailliard, RB .

MOLECULAR IMMUNOLOGY, 2005, 42 (04) :535-539

[18]

Lavergne E, 2003, CANCER RES, V63, P7468

[19] The IL-12 signature:: NK cell terminal CD56+high stage and effector functions [J].

Loza, MJ ;

Perussia, B .

JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :88-96

[20] Stabilization of IFN-γ mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells [J].

Mavropoulos, A ;

Sully, G ;

Cope, AP ;

Clark, AR .

BLOOD, 2005, 105 (01) :282-288

← 1 2 3 4 →